Volitionrx (VNRX) Long-Term Deferred Tax (2024)
Volitionrx (VNRX) reported Long-Term Deferred Tax of $41.9 million for Q4 2024.
Volitionrx (VNRX) Long-Term Deferred Tax (2024) Analysis & Trends
Volitionrx has reported Long-Term Deferred Tax for 1 years, with the latest figure at $41.9 million in Q4 2024.
- For the quarter ending Q4 2024, Long-Term Deferred Tax changed N/A year-over-year to $41.9 million; the trailing twelve-month figure through Dec 2024 stood at $41.9 million (changed N/A YoY), and the FY2024 full-year result was $41.9 million, changed N/A from the prior year.
- Long-Term Deferred Tax for Q4 2024 stood at $41.9 million.
- The five-year high for Long-Term Deferred Tax was $41.9 million in Q4 2024, with the low at $41.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Volitionrx | 53.00 Mn | 50.54 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 41.90 Mn |